Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-16

FDA Approved: CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% — Original Application (Allegis Holdings, LLC)

View source ↗

Summary

The FDA approved Allegis Holdings' clotrimazole topical solution 1% under an Original Application (ANDA), making a generic clotrimazole topical antifungal avail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% (clotrimazole topical solution 1%)

Snippet

ORIG AP for CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% (CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%)